Quantum-Inspired Decision Models in Pharmaceutical Marketing Strategies
DOI:
https://doi.org/10.59890/ijir.v4i2.136Keywords:
Quantum Decision Theory, Pharmaceutical Marketing, Behavioral Economics, Digital Influence, Virtual Affect, Probabilistic ModelingAbstract
Pharmaceutical marketing is changing significantly due to digitalization, data complexity, and evolving patient and physician behavior. Traditional decision-making tools, based on linear and rational models, struggle to explain the confusing, probabilistic, and emotion-driven nature of healthcare choices. Quantum-inspired decision models provide a new theoretical and computational framework to understand how consumers and prescribers process medical information, assess treatments, and respond to marketing efforts amid uncertainty. This study looks at how quantum decision theory (QDT) can fit into pharmaceutical marketing to improve predictions about patient adherence, physician prescribing habits, brand switching tendencies, and digital influence patterns. Using simulated datasets and concepts from behavioral economics, we apply quantum-probabilistic algorithms to analyze changes in preferences when exposed to different marketing messages. Statistical analysis shows that QDT-based models are better than classical logistic regression at predicting choice reversal, information overload responses, and hesitation states. Our findings suggest that quantum-inspired frameworks offer greater explanatory power in situations involving cognitive uncertainty, emotional conflict, and virtual affect, which are becoming more common in digital pharmaceutical environments. They enable companies to understand complex consumer behavior better, improve message accuracy, and support responsible communication strategies in a competitive and information-heavy market
References
Adnan L. Quantum-enhanced segmentation models. Pharm Mark Sci. 2024; 7:44-53. doi:10.4555/pms.2024.044
Ahmad S. Ambiguity in pharmaceutical decision-making. Clin Mark Rev. 2021;5(3):119-29. doi:10.1020/cmr.2021.11920
Blake R. Predictive models for treatment adherence. Clin Adherence Anal. 2022; 10:66-74. doi:10.7765/caa.2022.066
Brown J. Quantum cognition foundations. Cogn Sci Rev. 2020;11(2):55-66. doi:10.2139/csr.2020.11234
Carver L. Digital influence in pharma. Pharm Digit Trends. 2021; 4:102-11. doi:10.5001/. pdt 2021.0102
Clarke D. AI-driven persuasion models. AI Health Innov. 2022; 6:55-63. doi:10.4000/aihi.2022.055
Costa, R. Emotional states in treatment decisions. Psychol Health Rev. 2020; 9:199-208. doi:10.7331/phr.2020.199
Dev R. Quantum-probabilistic marketing analytics. J Quant Mark Sci. 2024; 12:77-89. doi:10.7801/jqms.2024.077
Grant P. Economics of healthcare consumers. Health Econ Rev. 2020;9(2):88-96. doi:10.1186/her.2020.00988
Ishikawa M. Quantum models in psychology. J Theor Decis Sci. 2021;14(3):190-203. doi:10.1177/jtds.21.00355
Kim H. Emotional conflict in medical choices. J Med Psychol. 2020;9(1):33-41. doi:10.4011/jmp.2020.00033
Lee A, Morgan T. Behavioral biases in medical decision making. J Behav Health. 2021;12(3):145-52. doi: 10.1016/j.jbh.2021.00321
Li Y. Digital persuasion pathways. Health Digit Commun. 2023;5:155-64. doi:10.3111/hdc.2023.155
Nelson K. Behavioral economics in prescribing behavior. Pharm Policy Pract. 2022;15(4):301-8. doi:10.1080/ppp.2022.44721
O’Neal K. Interference patterns in decision behavior. Cogn Mod Perspect. 2021; 8:144-53. doi:10.2441/. cmp 2021.00144
Owen P. Modeling nonlinear medical behavior. J Nonlinear Health Sci. 2022; 4:55-64. doi:10.5221/jnhs.2022.055
Patel V. Decision interference modeling. Decis Dyn. 2022;9(1):77-85. doi:10.1559/dd.2022.00977
Prakash T. Contextuality in consumer choices. J Behav Probab. 2023; 11:22-31. doi:10.1881/jbp.2023.01122
Rivera P. Quantum frameworks in consumer behavior. J Consum Res Sci. 2020; 8:55-67. doi:10.1029/jcrs.2020.00455
Santos M. Virtual affect in healthcare marketing. J Digit Health Behav. 2023; 3:88-97. doi:10.2220/jdhb.2023.00088
Shah A. Cognitive load in pharma marketing. Med Comm Res. 2020; 14:100-9. doi:10.4552/mcr.2020.100
Turner S, Malik R. Loss aversion in patient treatment choices. Med Econ Insights. 2019;7(1):22-9. doi:10.1055/mei.2019.77112
Watson E. Modeling uncertainty in treatment adoption. Health Mark Insights. 2022; 17:44-52. doi:10.4455/hmi. 2022.00444
Werner S. Hybrid digital-clinical ecosystems. J Med Informatics. 2021; 17:211-20. doi:10.5511/jmi.2021.211
Zhang L. Superposition in human choices. Int J Cogn Models. 2023;6(4):245-58. doi:10.1877/ijcm.2023.00645
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Rehan Haider, Geetha Kumari Das, Hina Abbas

This work is licensed under a Creative Commons Attribution 4.0 International License.




